Breaking News
Subscribe Now 0
Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 place See list
Close

GSK plc DRC (GSK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow GSK plc DRC's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
39.31 -0.94    -2.32%
04:20:37 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 4,613,581
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 39.19 - 40.37
Type:  Equity
Market:  United States
GSK plc DRC 39.31 -0.94 -2.32%

GSK Financial Summary

 
A brief financial summary of GSK plc DRC as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

GSK plc reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was GBP 7,884 million compared to GBP 7,178 million a year ago. Net income was GBP 1,173 million compared to GBP 1,624 million a year ago. Basic earnings per share from continuing operations was GBP 0.288 compared to GBP 0.401 a year ago. Diluted earnings per share from continuing operations was GBP 0.285 compared to GBP 0.397 a year ago.For the six months, sales was GBP 15,247 million compared to GBP 14,129 million a year ago. Net income was GBP 2,219 million compared to GBP 3,114 million a year ago. Basic earnings per share from continuing operations was GBP 0.545 compared to GBP 0.769 a year ago. Diluted earnings per share from continuing operations was GBP 0.539 compared to GBP 0.762 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

GSK Income Statement

Gross margin TTM 72.78%
Operating margin TTM 28.58%
Net Profit margin TTM 12.83%
Return on Investment TTM 25.42%
 Total Revenue  Net Income
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Total Revenue 7884 7363 8052 8147
Gross Profit 5822 5448 5237 5904
Operating Income 2215 2247 1639 2556
Net Income 1173 1046 350 1464

GSK Balance Sheet

Quick Ratio MRQ 0.5
Current Ratio MRQ 0.82
LT Debt to Equity MRQ 94.47%
Total Debt to Equity MRQ 117.89%
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Total Assets 58066 58511 59005 60862
Total Liabilities 44296 45282 46210 48243
Total Equity 13770 13229 12795 12619

GSK Cash Flow Statement

Cash Flow/Share TTM 1.83
Revenue/Share TTM 7.71
Operating Cash Flow  5.47%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 1113 958 3196 2212
Cash From Investing Activities 770 -149 268 -491
Cash From Financing Activities -1584 -1060 -3592 -1762
Net Change in Cash 291 -270 -162 -18
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GSK Comments

Write your thoughts about GSK plc DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email